Drug profile · INN
doxepin hydrochloride
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride (DOXEPIN HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Drug details — doxepin hydrochloride
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
doxepin hydrochloride (DOXEPIN HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter inhibitor
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is doxepin hydrochloride?
doxepin hydrochloride (DOXEPIN HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for doxepin hydrochloride?
DOXEPIN HYDROCHLORIDE is a marketed brand name for doxepin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of doxepin hydrochloride?
doxepin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.